Indexed keywords
BEVACIZUMAB;
SODIUM CHLORIDE;
VASCULOTROPIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
AQUEOUS HUMOR;
ARTICLE;
CONTROLLED STUDY;
CORNEA BURN;
CORNEA LIMBUS;
CORNEA NEOVASCULARIZATION;
DRUG EFFECT;
HISTOPATHOLOGY;
IMMUNOHISTOCHEMISTRY;
NONHUMAN;
TEAR FILM;
ADMINISTRATION, TOPICAL;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD31;
AQUEOUS HUMOR;
CORNEAL NEOVASCULARIZATION;
DISEASE MODELS, ANIMAL;
RABBITS;
TEARS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITREOUS BODY;
1
1842407860
Vascular development: cellular and molecular regulation
Beck L, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997, 11:365-75.
(1997)
FASEB J , vol.11
, pp. 365-375
Beck, L.1
D'Amore, P.A.2
2
85038193271
Angiogenesis and vasculogenesis for postnatal neovascularization
Isner JM, Ashara T. Angiogenesis and vasculogenesis for postnatal neovascularization. J Clin Invest 1993, 103:1231-6.
(1993)
J Clin Invest , vol.103
, pp. 1231-1236
Isner, J.M.1
Ashara, T.2
3
0028929803
Angiogenesis in cancer, vascular, rheumatoid and other diseases
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995, 1:27-31.
(1995)
Nat Med , vol.1
, pp. 27-31
Folkman, J.1
4
0024462727
Standard models of corneal injury using alkali-immersed filter disc
Ormerod LD, Abelson MB. Standard models of corneal injury using alkali-immersed filter disc. Invest Ophthalmol Vis Sci 1989, 30:2148-53.
(1989)
Invest Ophthalmol Vis Sci , vol.30
, pp. 2148-2153
Ormerod, L.D.1
Abelson, M.B.2
5
33646785007
Inhibition of corneal neovascularization by Rapamycin
Kwon YS, Kim JC. Inhibition of corneal neovascularization by Rapamycin. Exp Mol Med 2006, 38:173-9.
(2006)
Exp Mol Med , vol.38
, pp. 173-179
Kwon, Y.S.1
Kim, J.C.2
6
24044442902
Anti angiogenic activities of hypericin in vivo. Potential for ophthalmologic applications
Lavie G, Mandel M, Hazan S. Anti angiogenic activities of hypericin in vivo. Potential for ophthalmologic applications. Angiogenesis 2005, 8:35-42.
(2005)
Angiogenesis , vol.8
, pp. 35-42
Lavie, G.1
Mandel, M.2
Hazan, S.3
7
33645973257
Prevention and treatment of corneal graft rejection. Current practice patterns
Randleman JB, Stulting RD. Prevention and treatment of corneal graft rejection. Current practice patterns. Cornea 2006, 25:286-90.
(2006)
Cornea , vol.25
, pp. 286-290
Randleman, J.B.1
Stulting, R.D.2
8
0026723040
Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model
Gaudric A, Moenner M. Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model. Ophthalmic Res 1992, 24:181-8.
(1992)
Ophthalmic Res , vol.24
, pp. 181-188
Gaudric, A.1
Moenner, M.2
9
38549107051
Bevacizumab eye drops inhibit corneal neovascularization
Epub 2007 Oct 13
Bock F, König Y, Kruse F, Baier M, Cursiefen C. Bevacizumab eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008, 246:281-4. Epub 2007 Oct 13
(2008)
Graefes Arch Clin Exp Ophthalmol , vol.246
, pp. 281-284
Bock, F.1
König, Y.2
Kruse, F.3
Baier, M.4
Cursiefen, C.5
10
34247519047
Inhibition of experimental corneal neovascularization by Bevacizumab
Manzano RP, Peyman GA, Khan P. Inhibition of experimental corneal neovascularization by Bevacizumab. Br J Ophthalmol 2007, 91:804-7.
(2007)
Br J Ophthalmol , vol.91
, pp. 804-807
Manzano, R.P.1
Peyman, G.A.2
Khan, P.3
11
34548566924
The effects of the subconjunctival injection of bevacizumab on angiogenesis in the rat cornea
Barros FM, Belfort R. The effects of the subconjunctival injection of bevacizumab on angiogenesis in the rat cornea. An Acad Bras Cienc 2007, 79:389-94.
(2007)
An Acad Bras Cienc , vol.79
, pp. 389-394
Barros, F.M.1
Belfort, R.2
12
34548722080
Subconjunctival bevacizumab for corneal neovascularization
Erdurmuş M, Totan Y. Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2007, 245:1577-9.
(2007)
Graefes Arch Clin Exp Ophthalmol , vol.245
, pp. 1577-1579
Erdurmuş, M.1
Totan, Y.2
